Assignee
CHRONTECH PHARMA AB
SE·4 granted patents·10 pending applications·11 citations·filing 2006–2016
Top patents by PatentIndex Score
14 records- 0187US7968697B2Hepatitis C virus non-structural NS3/4A fusion geneCHRONTECH PHARMA AB·Filed 2006·Granted Jun 28, 2011·8 cites·22 claims
- 0284US7943149B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneCHRONTECH PHARMA AB·Filed 2009·Granted May 17, 2011·3 cites·8 claims
- 0369US2015051388A1Immunogen platformCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 0462US9079962B2Glycosylated specificity exchangersCHRONTECH PHARMA AB·Filed 2013·Granted Jul 14, 2015·0 cites·11 claims
- 0562US8658179B2Glycosylated specificity exchangersCHRONTECH PHARMA AB·Filed 2012·Granted Feb 25, 2014·0 cites·24 claims
- 0658US2013202554A1Compositions and methods that enhance an immune responseCHRONTECH PHARMA AB·Filed 2013·Application pending·0 cites
- 0758US2017058003A1Immunogen platformCHRONTECH PHARMA AB·Filed 2016·Application pending·0 cites
- 0856US2014286985A1Simple vaccines from dna launched suicidal flavivirusesCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 0955US2015252084A1Compositions and methods that enhance an immune responseCHRONTECH PHARMA AB·Filed 2015·Application pending·0 cites
- 1051US2016228531A1Treatment of hepatitis d virus infections by redirection of t cellsCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 1147US2016235928A1Injection needle and deviceCHRONTECH PHARMA AB·Filed 2016·Application pending·0 cites
- 1247US2016324954A1Immunogenic compositions for inhibiting hepatitis d virusCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 1346US2017216573A1Injection needle and deviceCHRONTECH PHARMA AB·Filed 2016·Application pending·0 cites
- 1444US2013012865A1Codon-optimzed hepatitis b virus core antigen (hbcag)CHRONTECH PHARMA AB·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →